Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2025-12-24 @ 11:28 PM
NCT ID:
NCT04349956
Eligibility Criteria:
Inclusion Criteria:
* Patients with knee OA who have completed a randomized placebo-controlled study of UBX0101.
* Patients who are willing and able to consent to having blinded, long-term follow-up; consent via legally authorized representative is not accepted.
Exclusion Criteria:
* Patients with any condition that, in the opinion of the Investigator, would likely interfere with adhering to the study schedule of visits for 12 months.
* Patients who are scheduled to undergo knee arthroplasty on either knee during the study.
* Patients who anticipate arthroscopic surgery on either knee at any time during the study.
* Patients who plan to receive treatment with an anti-nerve growth factor agent during the study.
* Patients who plan to participate in another investigational study (including interventional studies of investigational drugs and investigational treatments \[e.g., braces, stem cells, and procedures\]) during the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
85 Years
Study:
NCT04349956
Study Brief:
Protocol Section:
NCT04349956